1/24
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
whooping cough
an acute and highly contagious bacterial disease that affects the respiratory system
whooping cough bacteria
Bordetella pertussis
Bordetella pertussis
Gram negative coccobacillus
Obligate aerobe
Fastidious
whipping cough history
Outbreaks described since 16th century
Discovery of cause in 1906
Jules Bordet
Epidemics every 3-5 years
Incubation period for whooping cough
7-10 days
phase 1 of whooping cough
(Catarrhal)
• Cold-like symptoms
phase 2 of whooping cough
(Paroxysmal)
• Severe coughing “attack”, whooping sound, & vomiting
phase 3 of whooping cough
(Convalescent)
• Recession of previous symptoms
what does Bordetella pertussis attach to
respiratory cilia
what does Bordetella pertussis produce
pertussis toxin(AB type)
what does pertussis toxin do
paralyze cilia
what cant patients clear
pulmonary secretions
Pertussis Complications
• 25% develop pneumonia
• 4% develop seizures
• 1% suffer permanent brain damage
• 1% die
Whooping Cough Reservoirs
humans (no animals/insects)
Mainly adolescents or adults
whooping cough vectors
no vectors
how is whooping cough transmitted
in air via respiratory droplets
Mainly coughing and sneezing
who can get whopping cough
Anyone can get it – not vaccinated or improper vaccination or not
100% efficacy for vaccine
who is most adversely effected by whooping cough
Children under the age of 1 and seniors
Adolescent/adults partially protected by vaccine
milder symptoms
whooping cough treatment
rest and proper nutrition
antibiotic of choice
case isolation
antibiotics for whooping cough
Erythromycin (protein synthesis inhibitor)
Symptoms linger due to the pertussis toxin even though the infection is cleared.
macrolide resistance
what is emerging for whooping cough
macrolide resistance
How is Whooping Cough Prevented?
• Immunization
Commercially available vaccine mid 1930’s
Widely used in mid 1940’s
Pediatric formulation (DTaP)
Adolescent/Adult formulation (Tdap)
number of cases before and after vaccines
• Before vaccine: 200,000 cases/year in United States
• After vaccine: Average of 2,900 cases/year in United States from 1980-1990
cases of whooping cough are…
increasing since 1990